Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Pulmonary/Respiratory Diseases | Trauma (Emergency, Injury, Surgery) | Immunology | Family Medicine
 Disease Category: COPD (Chronic Obstructive Pulmonary Disease)
Location: United States, NC

Trial Information

52 week study for patients with COPD currently being treated with Spiriva

The purpose of this study is to asses the effectiveness, safety, and use patterns of indacaterol in COPD patients requiring adding daily maintenance therapy to their current LAMA therapy

Patient Inclusion criteria:

  • Age 40+
  • Smoking history of at least 10 pack years
  • urrently taking Spiriva

Patient Exclusion criteria:

  • Diagnosis of other respiratory disease (cystic fibrosis, tuberculosis, etc)
  • History of cancer in the past 5 years
  • Current use of Long-Acting Beta Antagonist (LABA)

Mary Preisel, Marketing/Clinical Research Coordinator
American Health Research
1918 Randolph Rd, Suite 440
Charlotte, NC 28207
Phone: 704-325-6700
Email: Mpreisel@ahres.com

View Map

Research Center Information: American Health Research

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:  
Message:
 

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.